Primerica, Inc. — 2021 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2021. This is an annual report, not a standalone fourth-quarter report; the filing text does not provide a clear set of Q4-only financial results.
Business context
Primerica distributes term life insurance, investment and savings products, Medicare-related insurance and other financial products primarily to middle-income households in the United States and Canada. Its distribution network included 129,515 life-licensed independent representatives at year-end. On July 1, 2021, Primerica acquired an 80% interest in e-TeleQuote, adding a Senior Health segment that distributes Medicare-related policies underwritten by third-party carriers.
Financial results and key metrics
| Metric | FY 2021 | FY 2020 | Change |
|---|---|---|---|
| Total revenue | $2.710 billion | $2.218 billion | Up 22% |
| Income before income taxes | $511.2 million | $506.7 million | Up 1% |
| Net income | $372.0 million | $386.2 million | Down 4% |
| Net income attributable to Primerica, Inc. | $373.4 million | $386.2 million | Down 3% |
| Diluted earnings per share | $9.38 | $9.57 | Down 2% |
| Operating cash flow | $657.0 million | $643.4 million | Up $13.5 million |
Net premiums were $1.506 billion, up 14%, while commissions and fees rose 39% to $1.043 billion. Net investment income declined 4% to $80.6 million. Total benefits and expenses increased 29% to $2.199 billion. The effective tax rate rose to 27.2% from 23.8%, principally reflecting the nondeductible goodwill impairment.
Segment pretax income (loss): Term Life Insurance earned $414.6 million, up 11%; Investment and Savings Products earned $274.6 million, up 36%; Senior Health recorded an $85.1 million loss; and Corporate and Other Distributed Products recorded a $93.0 million loss.
Selected operating indicators: Investment and savings product sales increased 49% to $11.704 billion; year-end client asset values increased to $97.312 billion from $81.533 billion, including $4.542 billion of net inflows. Term life face amount in force grew to $903.4 billion from $858.8 billion. The company reported approximately $63 million of 2021 life claims, net of reinsurance, above historical trends, most of the excess attributed to COVID-19.
Balance sheet and liquidity: Total assets were $16.123 billion and stockholders’ equity was $2.083 billion at year-end. Cash and cash equivalents were $392.5 million; the parent company reported $295.4 million of cash and invested assets. The company generated $657.0 million of operating cash flow and used $923.4 million in investing activities, including $494.5 million net cash paid for the e-TeleQuote acquisition. The $200 million revolving credit facility had no balance outstanding at year-end.
Debt: Primerica issued $600 million of 2.80% senior notes due 2031, using proceeds in part to redeem $375 million of 4.75% notes due 2022 and repay $125 million drawn on its revolver. The early redemption resulted in an $8.9 million extinguishment loss. A separate $15 million acquisition-related seller note was due in 2022; $9 million was repaid in January 2022, with the balance scheduled in installments through July 2022. The $1.379 billion surplus note is part of a reserve-financing arrangement and is matched by a held-to-maturity asset; the filing describes offsetting principal and interest while the asset is held.
Material changes, outlook and risks
- Revenue growth reflected stronger investment-product sales and asset-based fees, higher term-life premiums, and the partial-year addition of e-TeleQuote. Net income nevertheless declined as expenses grew, COVID-related claims increased, and acquisition-related items were recorded.
- Primerica recognized a $76 million noncash goodwill impairment for Senior Health. The segment’s results were affected by elevated policy churn, higher lead costs and agent attrition. e-TeleQuote’s estimated lifetime value of commissions to acquisition costs was 1.10 for 2021; these metrics have no comparable pre-acquisition period in the filing.
- Management said it expects operating cash flows to provide sufficient liquidity over the next 12 months and believes cash flows and potential funding sources will support long-term needs. The filing gives no quantified earnings or revenue guidance. Management expects to fund e-TeleQuote’s working-capital needs; parent-company funding provided during the second half of 2021 was $20 million, net of specified intercompany and tax-related items.
- COVID-19 continued to raise mortality costs and constrain recruiting and licensing. Management expects elevated mortality to normalize over time but says the timing and extent remain uncertain. Term-life persistency remained above pre-pandemic levels, though it eased from its peak.
- Canadian securities rules prohibit deferred sales charges on mutual funds beginning June 1, 2022. Primerica expects its revised mutual-fund compensation model to reduce pretax operating income initially, with potential recovery over time through asset-based revenue. Canadian insurance regulators also called for a transition away from deferred sales charges on segregated funds.
- Other significant risks include insurance and investment regulation, representative recruitment and independent-contractor classification, reinsurance counterparty performance, market and interest-rate exposure, cybersecurity, and integration and performance of e-TeleQuote. The company expects to adopt long-duration insurance accounting changes in 2023 and anticipates a significant reduction in accumulated other comprehensive income at adoption; the precise impact was not yet quantified.
- The financial statements received an unqualified audit opinion. Management and the auditor concluded internal control over financial reporting was effective, but e-TeleQuote’s controls were excluded from the assessment while integration proceeds. The filing says no pending legal proceeding required disclosure under Item 3.
Important facts for investors to verify
- Whether Senior Health policy retention, agent staffing, lead costs and unit economics improve, and whether further impairment or funding needs arise.
- The realized financial and cash-flow effects of Canada’s deferred-sales-charge changes, including the segregated-fund transition.
- COVID-related mortality experience, persistency trends and the availability, cost and collectability of reinsurance.
- Parent-company liquidity and subsidiary dividend capacity, given regulatory limits and planned support for e-TeleQuote.
- The eventual impact of the 2023 long-duration insurance accounting adoption on reserves, earnings and accumulated other comprehensive income.